Rindert Missiaen
Leuven, VLG 3000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
A powerful tool to study metabolic reprogramming in pediatric cancers.
Journal: Med (New York, N.Y.)
Published: May 19, 2022
GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment.
Journal: Cell metabolism
Published: May 20, 2021
Cell-Intrinsic Tumorigenic Functions of PPARγ in Bladder Urothelial Carcinoma.
Journal: Molecular cancer research : MCR
Published: February 25, 2020
Therapeutic induction of high endothelial venules (HEVs) to enhance T-cell infiltration in tumors.
Journal: Oncotarget
Published: October 09, 2017
Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations.
Journal: Cold Spring Harbor symposia on quantitative biology
Published: April 12, 2017
Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective.
Journal: Vascular pharmacology
Published: December 29, 2016
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.
Journal: Science translational medicine
Published: September 21, 2016
Last Updated: 09/26/2026